Impact Healthcare REIT

IHR offers long-term, inflation-linked income backed by a mix of public and private funding…

Disclosure – Non-substantive Research

This is not substantive investment research or a research recommendation, as it does not constitute substantive research or analysis. With this commentary, Kepler Partners LLP does not intend to influence your investment firm's behaviour. 

Impact Healthcare REIT

Impact Healthcare REIT (IHR) owns a portfolio of care homes which it lets to operators on long-dated, inflation-linked leases with upwards-only rent revisions. The tenants are responsible for the maintenance of the properties during the length of the lease, and contracts give IHR the right to rescind the leases if their financial performance deteriorates below a certain level (even if rent is being paid).

The manager, Impact Health Partners, has built a portfolio with a core of high-quality assets which are supplemented by those which it believes can be improved, thereby achieving an uplift to valuations. The sector is supported by an ageing population in the UK and limited supply of care-home places. This could be supportive of capital values over the whole sector, and also means that there are opportunities for asset management in providing accommodation for those suffering diseases whose prevalence rises with age, such as dementia.

Demand for the shares was strong until the current pandemic emerged, with IHR trading on a premium for long periods of time and issuing shares to grow the portfolio. However, the discount to NAV widened substantially in March, and has since narrowed to 10%. We discuss the impact of the pandemic on tenants in the Portfolio section; so far the full picture isn’t yet clear.

IHR’s shares yield 6.6%, and the board aims to grow the payout in line with the growth in the underlying rental income, which has a floor at +2% per annum and a cap at 4%. The rent due to IHR was covered 1.8 times by tenants’ operating profits as of the end of December.

Kepler View

IHR’s long-dated, inflation-linked cash flows with contractual minimum uplifts of 2% would surely see the shares trading on a premium if it weren’t for the uncertainty around the impact of COVID-19 on the health of residents and the finances of tenants. With the UK economy entering into a recession and likely to see many millions of unemployed over the coming months, income that is not dependent on the UK economy should be in high demand (and of course there is the impact of Brexit at the end of the year to consider).

We are optimistic that at the current stage of the epidemic – where it is fast receding, with prevalence at very low levels – a fuller picture of the impact will soon be clearer. The manager has stated that tenant defaults cannot be ruled out, although all the information they have given around costs and occupancy levels seems relatively positive to us. Of course, there is the potential for a second wave in the winter which could depress demand for the shares once again.

Given the discount some may see an opportunity here, and in the long run it seems that demand for care homes will remain high and the potential for yield should be good. That said, the uncertainty around the impact of the coronavirus means that investors need a reasonable degree of risk appetite in the short term.

bull bear
Attractive yield backed by long-dated, inflation-linked rental income Full impact of the pandemic on the finances of tenants is as yet unclear
Financial health of tenants has minimal exposure to the health of the UK economy Potential for regulatory interference in the sector
Demographic trends likely to support demand for the assets in a market with limited supply Rent smoothing means that dividends can be uncovered by cash income in the early years of contracts
Thomas McMahon
Thomas is a senior investment trust analyst and joined Kepler in April 2018. Previously he was senior analyst at FE Invest, where he was responsible for fund selection for a range of model portfolios. He covered all asset classes over time, but has particular experience with emerging markets and fixed income as well as UK smaller companies funds. He has a degree in Philosophy from Warwick University and is a CFA charterholder.

Related Research

Kepler Partners LLP considers this commentary to be a minor non-monetary benefit, as it:

1. Is intended to enhance the quality of service provided to you by us and is generic in nature;

2. Consists of short-term market commentary on the latest economic statistics and/or company results and/or information on upcoming releases or events;

3. Contains a brief summary of the author’s own opinion on such information;

4. Is not substantiated nor does it include any substantive analysis;

5. Reiterates the Kepler Partner LLP’s view on an existing recommendation or substantive research material; and/or

6. Is unlikely to impair your investment firm's compliance duty to act in the best interest of your client.

This report has been issued by Kepler Partners LLP for communication only to eligible counterparties and professional clients as defined by the Financial Conduct Authority.  Its contents may not be suitable for and are not to be communicated to or be relied on by retail clients. It is not an indication as to the suitability or appropriateness of investing in the security or securities discussed.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that Independent financial advice should be taken before entering into any financial transaction.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm’s internal rules. A copy of the firm’s Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Welcome to Kepler Trust Intelligence

Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority.
Please enter a valid email address
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid email address
{{item.msg}}
Please check your email. If an account exists you'll be sent instructions on how to reset your password.
Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority. To ensure that we are able to provide content which is appropriate for you, please tell us a little about yourself.
Please choose an option
{{item.msg}}
Please enter a company name
{{item.msg}}
Please enter a location name
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a platform
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a trust
{{item.msg}}
?
The information contained herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States to or for the benefit of any United States person (being residents of the United States or partnerships or corporations organised under the laws thereof). The investment funds referred to herein have not been registered in the United States under the Investment Company Act of 1940 and units or shares of such funds are not registered in the United States under the Securities Act of 1933.
Please confirm
{{item.msg}}
Please select an option
{{item.msg}}
See benefits
A free Kepler Trust Intelligence account allows you to access premium content including the ‘Kepler View’ – our verdict on the trusts we cover – and historical research so you can see how our view has changed over time. An account also unlocks useful facilities like the ‘follow’ button which lets you keep track of the trusts you’re interested in and as a logged in user you can also download PDFs of our research, and choose the layout of the page you’re reading to suit your preference. We will not share your details unless you give us permission to do so, and we won’t bombard you with emails – we only send one a week.
Please select an option
{{item.msg}}
Please enter your first name
{{item.msg}}
Please enter your last name
{{item.msg}}
Please enter a valid email address
An account already exists with this email - have you forgotten your password?
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid password
{{item.msg}}
Your answers help us to tailor our content to relevant investment trusts, and to ensure that the asset allocation and portfolio strategy research we produce is appropriate to our userbase. We do not share your personal information and your answers are not linked to your identity for marketing purposes.
Need help?

One more thing...

Did you know, you can 'follow' individual trusts on Kepler Trust Intelligence? Use the functions below to set up alerts and we'll send you research and updates on your chosen trusts.

Suggested trusts to follow

Browse all funds
Need help?
Current Site Kepler Trust Intelligence is produced by the investment companies team at Kepler Partners and is the UK’s premier source of detailed qualitative research on investment trusts. Absolute Hedge is a market leading UCITS research database providing proprietary research on funds, themes and strategies in the UCITS space. Kepler Liquid Strategies is a Dublin domiciled UCITS fund platform featuring a number of best-of-breed fund managers. Kepler Partners is a corporate advisory and asset raising boutique specialising in the regulated funds market in Europe and investment trusts in the UK.